ALK-targeted therapy for lung cancer: ready for prime time
ALK-targeted therapy for lung cancer: ready for prime time
About this item
Full title
Author / Creator
Publisher
United States: MJH Life Sciences Media
Journal title
Language
English
Formats
Publication information
Publisher
United States: MJH Life Sciences Media
Subjects
More information
Scope and Contents
Contents
Lung cancer remains the leading cause of cancer-related death in the United States. Ongoing research into the molecular basis of lung cancer has yielded insight into various critical pathways that are deregulated in lung tumorigenesis, and in particular key driver mutations integral to cancer cell survival and proliferation. One of the most recent...
Alternative Titles
Full title
ALK-targeted therapy for lung cancer: ready for prime time
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_887758796
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_887758796
Other Identifiers
ISSN
0890-9091
